Company Profile
Shouyao Holdings (Beijing) provides the research, development, and production of drugs in China. The company offers drugs for oncology indications, including non-small cell lung cancer, lymphoma, hepatocellular carcinoma, pancreatic cancer, breast cancer, ovarian cancer, thyroid cancer, leukemia, and diabetes. Founded in 2016, the company is headquartered in Beijing, China.